Is the increase in NO lung transfer due to free plasmatic hemoglobin in pulmonary arterial hypertension?

Herve Guenard (Bordeaux, France), Hervé Guénard, Claire Dromer, Delphine Bourlier, Christian Kays

Source: International Congress 2015 – Pulmonary hypertension in lung disease
Session: Pulmonary hypertension in lung disease
Session type: Thematic Poster Session
Number: 3764
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Herve Guenard (Bordeaux, France), Hervé Guénard, Claire Dromer, Delphine Bourlier, Christian Kays. Is the increase in NO lung transfer due to free plasmatic hemoglobin in pulmonary arterial hypertension?. Eur Respir J 2015; 46: Suppl. 59, 3764

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cardiac function in idiopathic pulmonary arterial hypertension patients with a severely reduced diffusion capacity
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015


Changes in red blood cell membrane structure in pulmonary arterial hypertension
Source: International Congress 2016 – Clinic of pulmonary hypertension
Year: 2016

Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target
Source: Eur Respir J 2011; 38: 1453-1460
Year: 2011



Pulmonary Function and response to treatment in pulmonary arterial hypertension (PAH)
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016

Evaluation of thyroid function in pulmonary arterial hypertension
Source: International Congress 2017 – PAH and CTEPH
Year: 2017

Assessment of platelet dysfunction in patients with pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016


Lung transplantation for pulmonary arterial hypertension
Source: International Congress 2015 – Lung transplantation in the year 2015: current indications and results
Year: 2015



Small airways dysfunction in chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – Dyspnoea and respiratory muscle mechanics dysfunction in disease
Year: 2015


Sildenafil improves heart rate variability, pulmonary hemodynamics and functional status in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014

Serum levels of microRNA-125a are decreased in patients with precapillary pulmonary hypertension and correlate inversely with hemodynamics
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

Analysis of pulmonary endothelial microparticles, haemodynamics and functional class in pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015

Pulmonary capillary recruitment in exercise and pulmonary hypertension
Source: Eur Respir J, 51 (3) 1702559; 10.1183/13993003.02559-2017
Year: 2018



Pulmonary capillary recruitment in exercise and pulmonary hypertension
Source: Eur Respir J, 51 (3) 1800260; 10.1183/13993003.00260-2018
Year: 2018



Pulmonary vascular reactivity in pulmonary hypertension due to left heart disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Apelin improves cardiac output in patients with pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015

The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease
Source: Eur Respir J 2013; 41: 217-223
Year: 2013



Impact on survival of pulmonary function abnormalities in pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009

Pulmonary hypertension in sickle cell disease
Source: Annual Congress 2007 - ACCP1 - Pulmonary hypertension in sickle cell disease
Year: 2007

Acute hyperoxic challenge improves haemodynamics & Pulmonary vascular stiffness in interstitial lung disease-associated pulmonary hypertension
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

The different nature of pulmonary vascular resistant and compliance in reduced and preserved ejection fraction heart failure and associated pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: right ventricular function, exercise and gas exchange
Year: 2014